Variant report
Variant | nsv590806 |
---|---|
Chromosome Location | chr3:82923361-83022387 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:7)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:7 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:82831608..82833347-chr3:82961368..82963419,2 | MCF-7 | breast: | |
2 | chr3:82975227..82977618-chr3:82982531..82984366,2 | MCF-7 | breast: | |
3 | chr3:82973939..82976504-chr3:82990521..82993011,2 | MCF-7 | breast: | |
4 | chr3:82997480..83000246-chr3:83000555..83002406,2 | MCF-7 | breast: | |
5 | chr3:82975227..82977618-chr3:82982531..82984366,2 | MCF-7 | breast: | |
6 | chr3:82997480..83000246-chr3:83000555..83002406,2 | MCF-7 | breast: | |
7 | chr3:82973939..82976504-chr3:82990521..82993011,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs533803326 | chr3:82931729-82931730 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs185598056 | chr3:82931786-82931787 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs565110252 | chr3:82931792-82931793 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs527460780 | chr3:82931818-82931819 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs551244189 | chr3:82931821-82931822 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs547747811 | chr3:82931872-82931873 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs567557764 | chr3:82931891-82931892 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs189326604 | chr3:82931905-82931906 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs549752453 | chr3:82931939-82931940 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs373799007 | chr3:82931944-82931945 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs569507403 | chr3:82932077-82932078 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs191372066 | chr3:82932157-82932158 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs560858274 | chr3:82932187-82932188 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs558344884 | chr3:82932219-82932220 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs35799375 | chr3:82932228-82932229 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs571841663 | chr3:82932237-82932238 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs566254529 | chr3:82932240-82932241 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs374829666 | chr3:82932252-82932253 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs183726690 | chr3:82932262-82932263 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs35108406 | chr3:82932274-82932275 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs66501635 | chr3:82932275-82932276 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs6807614 | chr3:82932295-82932296 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs13070676 | chr3:82932296-82932297 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs573991690 | chr3:82932335-82932336 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs542868372 | chr3:82932341-82932342 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs370257908 | chr3:82932432-82932433 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs149325798 | chr3:82932433-82932434 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs374820776 | chr3:82932447-82932448 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs556531388 | chr3:82932453-82932454 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs71112063 | chr3:82932455-82932456 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs146723598 | chr3:82932456-82932457 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs201987432 | chr3:82932457-82932458 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs188484290 | chr3:82932471-82932472 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs545511850 | chr3:82932472-82932473 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs145310560 | chr3:82932514-82932515 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs578220226 | chr3:82932530-82932531 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs527522018 | chr3:82932534-82932535 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs111854501 | chr3:82932539-82932540 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs181325389 | chr3:82932540-82932541 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs557088087 | chr3:82932542-82932543 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs561016167 | chr3:82932572-82932573 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs530023155 | chr3:82932580-82932581 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs543087994 | chr3:82932619-82932620 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs148010066 | chr3:82932704-82932705 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs185270692 | chr3:82932716-82932717 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs9824341 | chr3:82932744-82932745 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs572688725 | chr3:82932760-82932761 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs373146047 | chr3:82932761-82932762 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs528288592 | chr3:82932786-82932787 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs1496619 | chr3:82942040-82942041 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Melanoma | 18172304 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Wilms tumour | 21544195 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Breast cancer | 21858162 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Mental retardation | 17124404 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Autism | 20808228 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Medulloblastoma | 16783165 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Glioma | 20126413 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:82931600-82932800 | Enhancers | Dnd41 | blood |
2 | chr3:82942000-82943200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
3 | chr3:82942400-82943200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
4 | chr3:82943800-82944000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
5 | chr3:82976400-82977600 | Enhancers | HepG2 | liver |
6 | chr3:82976600-82977600 | Enhancers | Liver | Liver |
7 | chr3:82987800-82989200 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
8 | chr3:82987800-82989600 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
9 | chr3:82988600-82989000 | Enhancers | Spleen | Spleen |
10 | chr3:83010800-83011400 | Enhancers | Dnd41 | blood |
11 | chr3:83011400-83011800 | Weak transcription | Dnd41 | blood |
12 | chr3:83011800-83013000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
13 | chr3:83011800-83013000 | Enhancers | Dnd41 | blood |
14 | chr3:83012000-83012400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
15 | chr3:83012000-83012400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
16 | chr3:83012000-83012800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
17 | chr3:83012200-83012400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
18 | chr3:83020400-83023000 | Weak transcription | Psoas Muscle | Psoas |